FDA: Pramiracetam (aka Pramistar)

Cynthia Fernandez filed this request with the Food and Drug Administration of the United States of America.

It is a clone of this request.

Est. Completion None
Status
Fix Required

Communications

From: Cynthia Fernandez

To Whom It May Concern:

This is a request under the Freedom of Information Act. I hereby request the following records:

+ Documents produced by the FDA from January 1st, 2012 through August 15th, 2017, that mention Piracetam (2-(2-oxopyrrolidin-1-yl)acetamide) either by the aforementioned chemical or structural name, or by the trade name Nootropil, Breinox, Dinagen, Lucetam, Nootropyl, or Oikamid.
+ This request should be construed to include:
- White papers
- Opinions
- Internal and external emails and memorandum
- New Dietary Ingredient Notifications
- Investigational New Drug information
- Applications
- Data
- Import alerts
- Seizure notices
- Studies
- Chemical analysis/testing.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Cynthia Fernandez

From: Muckrock Staff

To Whom It May Concern:
I wanted to follow up on the following request, copied below. Please let me know when I can expect to receive a response.
Thanks for your help, and let me know if further clarification is needed.

From: Food and Drug Administration

Good morning,

For us to be able to look up your request, you will need to supply us with a request number. We receive so many requests from Muckrock, that it will be hard for us to pin point which request this belongs too.

Thank you,

Wilson M. Russ
Program Support Specialist
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8981
wilson.russ@fda.hhs.gov<mailto:wilson.russ@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

[cid:image002.jpg@01D1C57E.DFA022A0]<https://www.facebook.com/FDA> [cid:image003.jpg@01D1C57E.DFA022A0] <https://twitter.com/US_FDA> [cid:image004.jpg@01D1C57E.DFA022A0] <http://www.youtube.com/user/USFoodandDrugAdmin> [cid:image005.jpg@01D1C57E.DFA022A0] <http://www.flickr.com/photos/fdaphotos/> [cid:image006.jpg@01D1C57E.DFA022A0] <http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm>

Files